A gene that may change how well temozolomide works
Original title: Reduced DDB2 Expression Is Associated with Temozolomide Resistance in Glioblastoma Cells.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done on cells in a lab, not in people. It is a very early step.
This was only done in cells grown in a lab.
The short version
In lab tests, brain tumor cells with less of a gene called DDB2 were harder to kill with the drug temozolomide: A chemotherapy taken as a capsule, used for some brain tumors. Your team checks your blood counts while you are on it. See the glossary.
What was studied. Researchers used glioblastoma: A glioma that is given grade 4. Grade 4 is the highest grade there is. The tumor grows fast. Treatment usually starts soon after it is found. It often means surgery, and then radiation and chemotherapy. See the glossary cells grown in a lab. Some of these cells responded well to temozolomide: A chemotherapy taken as a capsule, used for some brain tumors. Your team checks your blood counts while you are on it. See the glossary and some resisted it. The team checked 84 DNA repair genes in the cells.
What they found. Out of the 84 genes, only DDB2 lined up with how well the drug worked. Cells that resisted the drug had less DDB2. When the team lowered DDB2 in a cell line called A172, the drug worked less well on those cells.
What this means, and what it doesn't
What it could mean: Doctors already check a marker called MGMT promoter methylation: MGMT is a gene whose protein repairs damage to a tumor's DNA. Methylation turns it down. Your report says how much, and your team uses that when they choose chemotherapy. The line between high and low is not settled. See the glossary to help guess how well temozolomide: A chemotherapy taken as a capsule, used for some brain tumors. Your team checks your blood counts while you are on it. See the glossary will work. But MGMT does not explain every case. This work points to DDB2 as one more thing worth studying.
What it doesn't mean: This was lab work on cells in a dish. No people took part. There is no new test or treatment for patients from this. It does not change your care today, and it is not a cure.
Source: PubMed, October 9, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.